Yajing Chen, Phd
AeroLeads people directory · profile

Yajing Chen, Phd Email & Phone Number

Chief Financial Officer at Zai Lab | Strategic Finance Business Partner | Biopharmaceutical Industry at Zai Lab
Location: Washington DC-Baltimore Area, United States, United States 13 work roles 3 schools
1 work email found @zailaboratory.com LinkedIn matched
4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email y****@zailaboratory.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Chief Financial Officer at Zai Lab | Strategic Finance Business Partner | Biopharmaceutical Industry
Location
Washington DC-Baltimore Area, United States, United States

Who is Yajing Chen, Phd? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Yajing Chen, Phd is listed as Chief Financial Officer at Zai Lab | Strategic Finance Business Partner | Biopharmaceutical Industry at Zai Lab, based in Washington DC-Baltimore Area, United States, United States. AeroLeads shows a work email signal at zailaboratory.com and a matched LinkedIn profile for Yajing Chen, Phd.

Yajing Chen, Phd previously worked as Chief Financial Officer at Zai Lab and Deputy Chief Financial Officer at Zai Lab. Yajing Chen, Phd holds Master Of Business Administration - Mba from Columbia Business School.

Company email context

Email format at Zai Lab

This section adds company-level context without repeating Yajing Chen, Phd's masked contact details.

*@zailaboratory.com
68% confidence

AeroLeads found 1 current-domain work email signal for Yajing Chen, Phd. Compare company email patterns before reaching out.

Profile bio

About Yajing Chen, Phd

Senior finance leader with 20 years of global experience in the life sciences at Zai Lab, AstraZeneca, and Quest Diagnostics. Business partner recognized for deep business acumen spanning R&D, sales, marketing, market access and operation. Skilled in establishing new processes, developing teams, and delivering challenging goals. PhD in Microbiology from New York University and MBA from Columbia Business School. Fluent in English and Chinese. Specialties: Finance, corporate finance, CFO, life sciences, pharmaceutical, biotechnology, biotech, biopharmaceutical, international, global, business partner, commercial, R&D, research, development, line management, supervision, financial analysis, analytical skills, decision support, decision making, problem solving, negotiation, strategy, strategic planning, process improvement, change management, leadership, executive leadership, management, team building, talent development, forecasting, budgeting, valuation, business development, alliance management, corporate development, due diligence, critical thinking, business acumen, financial modeling, financial planning, financial reporting, FP&A, GAAP, IFRS, project management, P&L, margin expansion, profit, growth, cost optimization, KPIs, board presentations, cross-functional collaboration, relationship building

Listed skills include Biotechnology, Forecasting, Pharmaceutical Industry, Biopharmaceuticals, and 11 others.

Current workplace

Yajing Chen, Phd's current company

Company context helps verify the profile and gives searchers a useful next step.

Zai Lab
Zai Lab
Chief Financial Officer at Zai Lab | Strategic Finance Business Partner | Biopharmaceutical Industry
AeroLeads page
13 roles · 26 years

Yajing Chen, Phd work experience

A career timeline built from the work history available for this profile.

Chief Financial Officer

Current

Zhangjiang Hi-tech Park, Pudong, Shanghai, CN

Zai Lab (ZLAB) is NASDAQ and HKEX dual listed commercial stage biopharmaceutical company with more than $200 million in revenue. We are focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.

Jul 2023 - Present

Deputy Chief Financial Officer

Zhangjiang Hi-tech Park, Pudong, Shanghai, CN

Sep 2021 - Jul 2023

Cfo, Us Oncology Business

Cambridge, Cambridgeshire, GB

Led a team of 20 finance professionals supporting a $4.3 billion business. Scope included commercial and market access strategy, decision support, FP&A, gross to net (GTN) accounting, and US alliance management. Grew profit 43% and revenue 34% revenue by shaping resource allocation for launches of new product and new indications.

2019 - 2021 ~2 yrs

Finance Controller, Global Oncology Business Unit

Cambridge, Cambridgeshire, GB

Led a global team of 8 supporting a $6B business. Scope included commercial strategy, pipeline prioritization, decision support for business development, FP&A, as well as finance business partner support to a $2 billion region that included Japan and China. Achieved 29% global revenue CAGR by facilitating establishment of new global oncology business unit.

2016 - 2019 ~3 yrs

Senior Finance Director, Global Oncology Therapeutic Area

Cambridge, Cambridgeshire, GB

Led development of 10-year strategic plan for oncology therapy area which guided business development, pipeline prioritization, and commercial strategy, enabling AZ to grow oncology revenue from $3 to $10 billion in 5 years.

2016 - 2016

R&D Global Project Finance Director

Cambridge, Cambridgeshire, GB

Guided strategy and provided financial decision support for late stage development of Imfinzi®. Enhanced R&D productivity and transformed clinical study design process by championing clinical study cost transparency. Earned CFO award for impact.

2013 - 2016 ~3 yrs

Commercial Finance Director, Specialty Care Business Unit

Cambridge, Cambridgeshire, GB

Led a team of 4 supporting $1 billion US specialty business. Scope included decision support, FP&A, and GTN accounting for Synagis®, FluMist®, Caprelsa®, and Faslodex®. Maintained Synagis revenue following change to treatment guidelines by influencing pricing and contracting strategies, as well as guiding resource allocation.

2012 - 2013 ~1 yr

Finance Director, Biologics R&D

Cambridge, Cambridgeshire, GB

Led a global team of 10 finance professionals managing a $600 million R&D budget. Expanded biologics portfolio by providing financial models used in negotiation of Amgen collaboration for co-development of 5 monoclonal antibodies (mABs) for treatment of inflammatory diseases.

2010 - 2012 ~2 yrs

Associate Finance Director, Biologics R&D

Cambridge, Cambridgeshire, GB

Following MedImmune acquisition, drove integration of biologics R&D capabilities and harmonization of R&D reporting.

2008 - 2010 ~2 yrs

Senior Finance Manager, Medimmune R&D

Cambridge, Cambridgeshire, GB

Enhanced R&D long range planning, portfolio prioritization, and R&D resource allocation decisions by implementing use of new-to-MedImmune valuation models, as well as providing total project cost visibility. Accelerated monthly close process 60% and increased forecast accuracy to 95% by redesigning financial processes.

2006 - 2008 ~2 yrs

Senior Finance Manager, Hospital Business

Secaucus, NJ, US

Responsible for finance and accounting in $800 million business within this $6 billion clinical laboratory company. Supervised 2 financial professionals. Established new reporting tool that provided first-ever insight into performance by client, payer, product, and market segment. Earned CEO award for impact.

2003 - 2006 ~3 yrs

Manager, Corporate Financial Planning And Analysis (Fp&A)

Secaucus, NJ, US

Provided financial oversight and decision support for strategic growth initiatives, capital investments, and corporate operational excellence programs.

2001 - 2003 ~2 yrs

Senior Financial Analyst

US

Generated $2 million in incremental revenue by leading project to improve the change fee revenue audit process.

2000 - 2001 ~1 yr
3 education records

Yajing Chen, Phd education

Master Of Business Administration - Mba

Columbia Business School

Doctor Of Philosophy - Phd, Microbiology

New York University

Bachelor Of Science - Bs, Biology

Wuhan University
FAQ

Frequently asked questions about Yajing Chen, Phd

Quick answers generated from the profile data available on this page.

What company does Yajing Chen, Phd work for?

Yajing Chen, Phd works for Zai Lab.

What is Yajing Chen, Phd's role at Zai Lab?

Yajing Chen, Phd is listed as Chief Financial Officer at Zai Lab | Strategic Finance Business Partner | Biopharmaceutical Industry at Zai Lab.

What is Yajing Chen, Phd's email address?

AeroLeads has found 1 work email signal at @zailaboratory.com for Yajing Chen, Phd at Zai Lab.

Where is Yajing Chen, Phd based?

Yajing Chen, Phd is based in Washington DC-Baltimore Area, United States, United States while working with Zai Lab.

What companies has Yajing Chen, Phd worked for?

Yajing Chen, Phd has worked for Zai Lab, Astrazeneca, Quest Diagnostics, and Us Airways.

How can I contact Yajing Chen, Phd?

You can use AeroLeads to view verified contact signals for Yajing Chen, Phd at Zai Lab, including work email, phone, and LinkedIn data when available.

What schools did Yajing Chen, Phd attend?

Yajing Chen, Phd holds Master Of Business Administration - Mba from Columbia Business School.

What skills is Yajing Chen, Phd known for?

Yajing Chen, Phd is listed with skills including Biotechnology, Forecasting, Pharmaceutical Industry, Biopharmaceuticals, Mergers And Acquisitions, Analysis, Cross Functional Team Leadership, and Finance.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.